跳至主要内容
临床试验/NCT03966911
NCT03966911已完成不适用

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Medtronic Diabetes29 个研究点 分布在 1 个国家目标入组 335 人开始时间: 2019年6月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
335
试验地点
29
主要终点
Percentage of Readings Within 20% Agreement

研究概览

简要总结

The purpose of this study is to demonstrate the performance of the Guardian™ Sensor (3) with an advanced algorithm in subjects age 2 - 80 years, for the span of 170 hours (7 days).

详细描述

The study is a multi-center, prospective, single-sample correlational design without controls. The purpose of this study is to demonstrate the performance of the Guardian™ Sensor (3) with an advanced algorithm in subjects age 2 - 80 years, for the span of 170 hours (7 days).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
2 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individual is 2 - 80 years of age at time of enrollment
  • A clinical diagnosis of type 1 or 2 diabetes for a minimum of 6 months duration as determined via medical record or source documentation by an individual qualified to make a medical diagnosis
  • Adequate venous access as assessed by investigator or appropriate staff
  • Subjects participating in the high and low glucose challenges must have an insulin carbohydrate ratio(s) and insulin sensitivity ratio. Subjects without ratios may participate under observation only

排除标准

  • Subject will not tolerate tape adhesive in the area of Guardian™ Sensor (3) placement as assessed by a qualified individual.
  • Subject has any unresolved adverse skin condition in the area of sensor or device placement (e.g., psoriasis, rash, Staphylococcus infection)
  • Subject is actively participating in an investigational study (drug or device) wherein they have received treatment from an investigational study (drug or device) in the last 2 weeks
  • Subject is female and has a positive pregnancy screening test
  • Female of child bearing age and who is sexually active should be excluded if she is not using a form of contraception deemed reliable by investigator
  • Subject is female and plans to become pregnant during the course of the study
  • Subject has had a hypoglycemic seizure within the past 6 months prior to enrollment
  • Subject has had hypoglycemia resulting in loss of consciousness within the past 6 months prior to enrollment.
  • Subject has had an episode of diabetic ketoacidosis (DKA) within the past 6 months prior to enrollment.
  • Subject has a history of a seizure disorder
  • Subject has central nervous system or cardiac disorder resulting in syncope
  • Subject has a history of myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack (TIA), cerebrovascular accident (CVA), angina, congestive heart failure, ventricular rhythm disturbances or thromboembolic disease
  • Subject has a hematocrit (Hct) lower than the normal reference range (please note that patients may use prior blood draw from routine care as long as done within 6 months of screening and report of lab placed with subject source documents)
  • Subject has a history of adrenal insufficiency
  • Subject is a member of the research staff involved with the study.

结局指标

主要结局

Percentage of Readings Within 20% Agreement

时间窗: 7 days (170 hours)

Mean of daily percentage of sensor values within 20% of Yellow Springs Instrument (YSI™\*) reference value (within 20 mg/dL if sensor values \< 80 mg/dL), across all participants and all Frequent Sample Testing (FST) days. Note Self-Monitoring Blood Glucose (SMBG) was used for age 2-6, instead of YSI.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验